113 related articles for article (PubMed ID: 30939201)
21. Selective GPR55 antagonism reduces chemoresistance in cancer cells.
Singh NS; Bernier M; Wainer IW
Pharmacol Res; 2016 Sep; 111():757-766. PubMed ID: 27423937
[TBL] [Abstract][Full Text] [Related]
22. Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha.
Riganti C; Doublier S; Aldieri E; Orecchia S; Betta PG; Gazzano E; Ghigo D; Bosia A
Eur Respir J; 2008 Aug; 32(2):443-51. PubMed ID: 18385176
[TBL] [Abstract][Full Text] [Related]
23. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
24. Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H
Du B; Ding X; Wang H; Du Q; Xu T; Huang J; Zhou J; Cheng G
J Mater Chem B; 2019 Aug; 7(31):4784-4793. PubMed ID: 31389949
[TBL] [Abstract][Full Text] [Related]
25. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.
Zhang YL; Guo KP; Ji SY; Liu XM; Wang P; Wu J; Gao L; Jiang TQ; Xu T; Fan HY
Hum Reprod; 2016 Jan; 31(1):169-82. PubMed ID: 26621853
[TBL] [Abstract][Full Text] [Related]
27. Activation of hypoxia-inducible factor-1α by prolonged in vivo hyperinsulinemia treatment potentiates cancerous progression in estrogen receptor-positive breast cancer cells.
Wang L; Fan J; Yan CY; Ling R; Yun J
Biochem Biophys Res Commun; 2017 Sep; 491(2):545-551. PubMed ID: 28351619
[TBL] [Abstract][Full Text] [Related]
28. HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
Xiang L; Gilkes DM; Hu H; Luo W; Bullen JW; Liang H; Semenza GL
Oncotarget; 2015 May; 6(14):11768-78. PubMed ID: 26059435
[TBL] [Abstract][Full Text] [Related]
29. Tumor cells upregulate normoxic HIF-1α in response to doxorubicin.
Cao Y; Eble JM; Moon E; Yuan H; Weitzel DH; Landon CD; Nien CY; Hanna G; Rich JN; Provenzale JM; Dewhirst MW
Cancer Res; 2013 Oct; 73(20):6230-42. PubMed ID: 23959856
[TBL] [Abstract][Full Text] [Related]
30. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
[TBL] [Abstract][Full Text] [Related]
31. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
[TBL] [Abstract][Full Text] [Related]
32. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α.
Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
[TBL] [Abstract][Full Text] [Related]
33. [Reversion the multidrug resistance of human breast carcinoma cells by RNA interference targeting HIF-1 alpha gene].
Ma C; Zhou GY; Xiao Y; Gao P; Zhang CJ
Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):357-60. PubMed ID: 16834911
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
[TBL] [Abstract][Full Text] [Related]
35. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
36. The FSH-HIF-1α-VEGF Pathway Is Critical for Ovulation and Oocyte Health but Not Necessary for Follicular Growth in Mice.
Li C; Liu Z; Li W; Zhang L; Zhou J; Sun M; Zhou J; Yao W; Zhang X; Wang H; Tao J; Shen M; Liu H
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32141513
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin-Induced Autophagolysosome Formation Is Partly Prevented by Mitochondrial ROS Elimination in DOX-Resistant Breast Cancer Cells.
Ahmadpour ST; Desquiret-Dumas V; Yikilmaz U; Dartier J; Domingo I; Wetterwald C; Orre C; Gueguen N; Brisson L; Mahéo K; Dumas JF
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502189
[TBL] [Abstract][Full Text] [Related]
38. Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity.
Fang Y; Sullivan R; Graham CH
Exp Cell Res; 2007 Mar; 313(5):867-77. PubMed ID: 17289019
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha.
Cascio S; Bartella V; Auriemma A; Johannes GJ; Russo A; Giordano A; Surmacz E
Oncogene; 2008 Jan; 27(4):540-7. PubMed ID: 17653093
[TBL] [Abstract][Full Text] [Related]
40. Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
Bontempo A; Ugalde-Villanueva B; Delgado-González E; Rodríguez ÁL; Aceves C
Oncol Rep; 2017 Nov; 38(5):2867-2876. PubMed ID: 28901484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
